IT:JXUE ETF Price & Analysis
JXUE ETF Chart & Stats
€22.09
--
Market closed
€22.09
--
Day’s Range― - ―
52-Week Range€21.61 - €23.22
Previous Close€22.09
VolumeN/A
Average Volume (3M)578.00
AUM582.71K
NAV22.08
Expense Ratio0.31%
Holdings Count286
Beta0.46
Inception DateJun 16, 2026
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume43
30 Day Avg. Volume578
AlphaN/A
ETF Overview
JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF Accum- EUR
JPMorgan ETFs (Ireland) ICAV – Global ex US Research Enhanced Index Equity Active UCITS ETF Accum (EUR) is an actively managed, UCITS‑regulated exchange‑traded fund designed to provide broad, long‑term exposure to the global equity market outside the United States while seeking to outperform its benchmark through research‑driven stock selection and portfolio construction.
What it does
- Provides diversified exposure to equities across developed and emerging markets excluding the US, covering a wide range of market capitalizations (total‑market orientation).
- Combines a broad, core equity footprint with an active “research enhanced” approach: proprietary quantitative and fundamental research informs stock selection, factor tilts and portfolio weights with the aim of generating incremental return versus the benchmark.
- Operates within an index‑aware, actively managed framework that seeks to balance the pursuit of excess return with controls on tracking error and overall portfolio risk.
Key features
- Broad‑based, total‑market focus outside the US: offers a single ETF solution for investors wanting a core international equity allocation without US exposure.
- Size and style emphasis: research inputs can create deliberate size and style exposures (e.g., small/large cap and growth/value insights) across the total market to enhance return potential.
- Accumulating (EUR) share class: income from holdings is reinvested into the fund, supporting compounding and long‑term capital growth; denominated in euros.
- UCITS structure and Ireland domicile: provides investor protections and standardised governance and diversification limits expected of UCITS funds.
Who it’s for
- Investors seeking a core non‑US equity allocation but wanting an actively‑managed, research‑driven strategy rather than passive replication.
- Suitable for long‑term investors prioritising capital growth and willing to accept the additional active risk that comes with attempts to outperform a benchmark.
Risks and considerations
- Exposes investors to market, currency and country risks outside the US; performance may diverge from plain index replication due to active decisions and factor tilts.
- As an active ETF, potential for tracking error and periods of underperformance versus the benchmark should be expected.
In short, JXUE aims to deliver broad, non‑US equity market coverage while using JPMorgan’s research capabilities to enhance returns—making it a convenient, single‑ticket solution for investors seeking an actively managed international equity sleeve outside the United States.
JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF Accum- EUR (JXUE) Fund Flow Chart
JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF Accum- EUR (JXUE) 1 year Net Flows: €142K
JXUE ETF News
JXUE ETF FAQ
What was IT:JXUE’s price range in the past 12 months?
IT:JXUE lowest ETF price was €21.61 and its highest was €23.22 in the past 12 months.
What is the AUM of IT:JXUE?
As of Oct 13, 2026 The AUM of IT:JXUE is 582.71K.
Is IT:JXUE overvalued?
According to Wall Street analysts IT:JXUE’s price is currently Undervalued.
Does IT:JXUE pay dividends?
IT:JXUE does not currently pay dividends.
How many shares outstanding does IT:JXUE have?
Currently, no data Available
Which hedge fund is a major shareholder of IT:JXUE?
Currently, no hedge funds are holding shares in IT:JXUE
Top 10 Holdings
ASML Holding NV
3.30%
Siemens Ag (UK)
1.54%
AstraZeneca plc
1.46%
Shell plc (UK)
1.32%
Allianz SE (UK)
1.31%
Hsbc Holdings Plc (UK)
1.26%
Banco Santander SA
1.25%
Roche Holding
1.20%
Tokyo Electron
1.13%
Nestlé
1.12%
Total14.88%
See All Holdings












